Haigh P I, Ituarte P H, Wu H S, Treseler P A, Posner M D, Quivey J M, Duh Q Y, Clark O H
Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Cancer. 2001 Jun 15;91(12):2335-42.
The prognosis of anaplastic thyroid carcinoma (ATC) has been dismal. The objective of this study was to identify prognostic factors in patients who had prolonged survival.
Patients with ATC were identified from a computer database at a tertiary referral center. Univariate and multivariate analyses for survival differences were performed using the Kaplan-Meier log-rank statistic and the Cox proportional hazards model, respectively.
Of the 33 evaluable patients, median survival was 3.8 months. Median age was 69 years. Prior goiter was present in 6 patients (18%), and 6 (18%) had prior thyroid carcinoma. Median tumor size was 6 cm, and 12 (36%) had adjacent well-differentiated carcinoma. Of the 26 patients who underwent neck exploration, 8 patients were potentially cured and received postoperative chemotherapy and irradiation; 4 (50%) were surgically macroscopically free of disease, and 4 (50%) patients had minimal residual disease after total thyroidectomy and resection of tumor adherent to adjacent structures. Four of these 8 patients survived longer than 2 years; their 5-year survival estimate was 50%. Eighteen patients underwent palliative resection of neck disease, leaving macroscopic residual disease or distant metastases; postoperative adjuvant chemotherapy and irradiation were administered in 16 of these 18 patients. Seven patients were treated with only chemotherapy and irradiation. In patients treated with potentially curative resection, median survival was 43 months compared with 3 months with palliative resection (P =0.002); the median survival of 3.3 months with only chemotherapy and irradiation was no different than palliative resection (P =0.63). No association was found between survival and age, prior goiter, prior thyroid carcinoma, adjacent differentiated carcinoma, or tumor size.
Although the prognosis of most patients with ATC continues to be poor, complete resection of ATC combined with postoperative adjuvant chemotherapy and irradiation resulted in long-term survival, even with persistent minimal disease that remained on vital structures. An aggressive attempt at maximal tumor debulking followed by adjuvant therapy was found to be warranted in patients with localized ATC.
间变性甲状腺癌(ATC)的预后一直很差。本研究的目的是确定生存期延长患者的预后因素。
从一家三级转诊中心的计算机数据库中识别出ATC患者。分别使用Kaplan-Meier对数秩统计量和Cox比例风险模型对生存差异进行单因素和多因素分析。
在33例可评估患者中,中位生存期为3.8个月。中位年龄为69岁。6例患者(18%)既往有甲状腺肿,6例(18%)既往有甲状腺癌。肿瘤中位大小为6cm,12例(36%)有相邻的高分化癌。在接受颈部探查的26例患者中,8例患者有可能治愈并接受了术后化疗和放疗;4例(50%)手术肉眼无疾病残留,4例(50%)患者在全甲状腺切除及切除与相邻结构粘连的肿瘤后有微小残留疾病。这8例患者中有4例生存期超过2年;其5年生存率估计为50%。18例患者接受了颈部疾病的姑息性切除,术后有肉眼残留疾病或远处转移;这18例患者中有16例接受了术后辅助化疗和放疗。7例患者仅接受化疗和放疗。在接受潜在根治性切除的患者中,中位生存期为43个月,而姑息性切除患者为3个月(P =0.002);仅接受化疗和放疗患者的中位生存期为3.3个月,与姑息性切除无差异(P =0.63)。未发现生存期与年龄、既往甲状腺肿、既往甲状腺癌、相邻分化癌或肿瘤大小之间存在关联。
尽管大多数ATC患者的预后仍然很差,但ATC的完全切除联合术后辅助化疗和放疗可导致长期生存,即使重要结构上仍有持续的微小疾病残留。对于局限性ATC患者,积极尝试最大限度地减少肿瘤负荷并随后进行辅助治疗是必要的。